Eraslan, E. and Doğan, M. 2021. Platelet-to-lymphocyte Ratio (PLR) as an Indicator of Survival in Rare Histopathological Subtypes of Renal Cell Carcinoma. Medical Science and Discovery. 8, 4 (Apr. 2021), 283–288. DOI:https://doi.org/10.36472/msd.v8i4.535.